Number of the records: 1  

New DHA derivaties and their use as medicaments

  1. 1.
    SYSNO ASEP0335327
    Document TypeP - Patent
    R&D Document TypePatent or other outcome protected by special legislation
    TitleNew DHA derivaties and their use as medicaments
    TitleNové deriváty DHA a jejich léčebné využití
    Author(s) Bryhn, M. (NO)
    Kopecký, Jan (FGU-C) RID, ORCID
    Holmeide, A.K. (NO)
    Year of issue2009
    Possible third party use of the resultA - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence
    Royalty requestedA - Poskytovatel licence požaduje licenční poplatek
    Patent no. or utility model no. or industrial design no.US 7,550,613 B2
    Date of the patent acceptance23.06.2009
    Name of the patent ownerPronova BioPharma Norge AS
    Current useA - Pouze udělený (dosud nevyužívaný) patent nebo patent využívaný jeho vlastníkem
    Languageeng - English
    CountryUS - United States
    KeywordsDHA ; diabetes type 2
    Subject RIVFB - Endocrinology, Diabetology, Metabolism, Nutrition
    R&D ProjectsGA303/08/0664 GA ČR - Czech Science Foundation (CSF)
    1M0520 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    GA303/07/0708 GA ČR - Czech Science Foundation (CSF)
    OC08007 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    OC08008 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    CEZAV0Z50110509 - FGU-C (2005-2011)
    AnnotationNew chemicals derivatives of docosahexaenoic acid have been developed. The derivatives can reduce adipose tissue inflammation and insulin resistance in mice fed high-fat diet. The derivatives could be used as medicaments to treat insulin resistance in diabetic patients
    WorkplaceInstitute of Physiology
    ContactLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Year of Publishing2010
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.